Publication | Open Access

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

InflammationPhase 1BImmunologySepsisImmune Checkpoint InhibitorImmunosuppressionImmunotherapyMedicineImmune Checkpoint Inhibition